![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessChanges in tumour vessel density upon treatment with anti-angiogenic agents: relationship with response and resistance to therapy
We examine how changes in a surrogate marker of tumour vessel density correlate with response and resistance to anti-angiogenic therapy.
-
Article
Open AccessPrognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma
Objectively measured circulating biomarkers of prognosis complementing existing clinicopathological models are needed in renal cell carcinoma (RCC).
-
Article
Open AccessImproving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein
Validated objective biomarkers are needed for patients with renal cell carcinoma (RCC) to guide patient management and define high-risk populations for follow-up or for therapeutic purposes.
-
Article
Open AccessAssociation of serum amyloid A protein and peptide fragments with prognosis in renal cancer
In renal cell carcinoma (RCC), the discovery of biomarkers for clinical use is a priority. This study aimed to identify and validate diagnostic and prognostic serum markers using proteomic profiling.
-
Article
Open AccessPre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma
No circulating markers are routinely used for renal cancer. The objective of this pilot study was to investigate whether conditioned media (CM) from renal cancer cell lines contains potential biomarkers that, ...